Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany

2018 ◽  
Vol 261 ◽  
pp. 90-93 ◽  
Author(s):  
Karel Kostev ◽  
Louis Jacob
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Oral Antihyperglycemic Drugs

scholarly journals Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Across the Spectrum of Hypertension

2019 ◽  
Author(s):  
Elias A Sanidas ◽  
Dimitrios P Papadopoulos ◽  
Erifili Hatziagelaki ◽  
Charalampos Grassos ◽  
Maria Velliou ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Arterial Hypertension ◽  
Sglt2 Inhibitors ◽  
Glucose Lowering ◽  
Sodium Glucose Cotransporter ◽  
Robust Evidence ◽  
Oral Antihyperglycemic Drugs

Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors represent a novel class of oral antihyperglycemic drugs that have been approved over the last decade for the management of type 2 diabetes mellitus. Except the glucose-lowering effects, robust evidence also suggests that SGLT2 inhibitors confer benefits in cardiovascular system. The purpose of this review was to investigate the effects of SGLT2 inhibitors across the spectrum of arterial hypertension.

scholarly journals Utilization Pattern Study Of Oral Antihyperglycemic Drugs In Type 2 Diabetes Mellitus In Diabetic Outpatient Care

2018 ◽  
Vol 4 (2) ◽  
pp. 52-55
Author(s):  
Nitin Purushottam Joglekar ◽  
Purushottam Ramakrishna Joglekar
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Educational Status ◽  
Pharmaceutical Companies ◽  
Prescription Pattern ◽  
Combination Drugs ◽  
Study Population ◽  
Oral Antihyperglycemic Drugs

The Aim of the present study is to analyze prescription pattern of the antihyperglycemic drugs in patients with type 2 diabetes mellitus (T2DM). The study included 620 T2DM out patients aged between 41 to 60 years. Sociodemographic data included mean age, educational status, marital status, duration of diabetes mellitus and BMI. Women (54.8%) shared higher percentage in study population. Metformin (44.1%) was prescribed significantly in higher cases than other antihyperglycemic drugs. Glimepiride (30%) is second most common drug prescribed in monotherapy followed by glibenclamide (9.3%), gliclazide (6.6%) in treatment of T2DM. The prescription pattern study of antihyperglycemic drugs in T2DM can serve as a guide to clinicians to select the monotherapy drug, combination drugs and insulin preparations. The findings of current study also help to the pharmaceutical companies to understand the percentage of utilization of antidiabetic drugs before developing and marketing any new drug.

Abstract #1214: Decreasing Hypoglycemia Without Compromising Efficacy in an Aging Type 2 Diabetes Mellitus (T2Dm) Population

2015 ◽  
Vol 21 ◽  
pp. 280-281
Author(s):  
Medha Munshi ◽  
Jasvinder Gill ◽  
Jason Chao ◽  
Elena Nikonova ◽  
Andreas Stuhr ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus

Abstract #517: Predicting Risk of Osteoporotic Fracture by Bone Ultrasonography in Type 2 Diabetes Mellitus

2015 ◽  
Vol 21 ◽  
pp. 106
Author(s):  
Franco Grimaldi ◽  
Laura Tonutti ◽  
Claudia Cipri ◽  
Cecilia Motta ◽  
Maria Antonietta Pellegrini ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Osteoporotic Fracture ◽  
Bone Ultrasonography
Sign in / Sign up

Export Citation Format

Share Document